Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 12.53B | 7.00%11.94B | 2.44%47.62B | 4.40%12.5B | 2.93%11.15B | 4.71%46.48B | 2.87%12.4B | 4.86%11.28B | 11.21%11.97B | 0.14%10.84B |
| Cost of revenue | 3.82B | 14.98%3.6B | -2.43%14.35B | 1.44%4.09B | 4.47%3.13B | 9.79%14.71B | 4.80%4.13B | 16.96%3.56B | 36.46%4.03B | -13.56%3B |
| Gross profit | 8.72B | 3.88%8.34B | 4.70%33.27B | 5.92%8.41B | 2.33%8.02B | 2.51%31.77B | 1.93%8.28B | 0.08%7.72B | 1.66%7.94B | 6.59%7.84B |
| Operating expense | 7.73B | -0.05%7.72B | -0.82%32.97B | -0.14%8.51B | -3.69%7.72B | -3.52%33.24B | -5.35%8.78B | -7.79%7.92B | 0.21%8.52B | -0.82%8.02B |
| Operating profit | 983M | 103.96%618M | 120.55%301M | 82.53%-102M | 272.16%303M | 57.61%-1.47B | 56.34%-506M | 77.23%-199M | 16.09%-584M | 75.79%-176M |
| Net non-operating interest income (expenses) | -89M | 12.84%-95M | 7.62%-473M | 8.89%-123M | 23.24%-109M | 5.71%-512M | 14.71%-116M | 9.85%-119M | 3.57%-135M | -5.19%-142M |
| Non-operating interest income | --22M | 950.00%21M | 250.00%7M | --0 | 100.00%2M | 100.00%2M | --1M | --0 | --0 | --1M |
| Non-operating interest expense | --111M | 6.42%116M | 0.21%478M | 1.65%123M | -9.17%109M | -12.32%477M | -13.97%117M | -10.53%119M | -13.57%121M | -11.11%120M |
| Total other finance cost | ---- | ---- | -94.59%2M | --0 | -91.30%2M | --37M | --0 | --0 | --14M | --23M |
| Net investment income | 39M | -246.15%-76M | 117.07%89M | -3.33%58M | 1,633.33%52M | -33.87%41M | 24.19%-47M | -40.48%25M | 9.09%60M | -88.89%3M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 0 | 2,423.53%395M | 460.00%18M | 326M | -105.15%-17M | 76.60%-11M | -1M | -5M | 0 |
| Income from associates and other participating interests | -26M | -44.44%5M | 1,300.00%42M | 416.67%19M | 550.00%9M | -94.83%3M | -30.77%9M | -80.00%2M | -135.29%-6M | -111.11%-2M |
| Special income (charges) | 1M | 67.74%-261M | -65.63%-1.11B | -15,050.00%-303M | -2,889.66%-809M | -319.61%-672M | -60.00%-696M | -100.62%-3M | -103.64%-2M | -85.71%29M |
| Less:Restructuring and mergern&acquisition | ---1M | --262M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | --0 | ---1M | -103.96%-22M | ---- | ---- | 174.90%555M | --579M | 100.62%3M | 103.64%2M | 85.71%-29M |
| Less:Write off | --0 | --0 | 870.09%1.14B | --285M | --809M | -73.10%117M | ---- | ---- | --0 | --0 |
| Other non-operating income (expenses) | 61M | -254.55%-17M | -10.98%454M | -81.62%25M | -94.69%11M | -38.70%510M | -50.00%36M | 274.29%131M | 325.00%136M | -70.13%207M |
| Income before tax | 972M | 181.02%175M | 85.55%-305M | 24.02%-408M | -166.67%-216M | 12.34%-2.11B | 24.13%-1.33B | -174.58%-162M | 20.80%-537M | -197.59%-81M |
| Income tax | 367M | 180.84%329M | -113.00%-71M | -62.32%78M | -567.82%-407M | 100.74%546M | 21.57%62M | -46.33%190M | 220.35%207M | 123.08%87M |
| Net income | 606M | -180.63%-154M | 91.23%-233M | 34.90%-485M | 213.69%191M | 0.86%-2.66B | 22.78%-1.39B | 15.22%-351M | -47.23%-745M | -481.82%-168M |
| Net income continuous operations | --605M | -180.63%-154M | 91.19%-234M | 34.68%-486M | 213.69%191M | 0.86%-2.66B | 22.84%-1.39B | 14.77%-352M | -47.04%-744M | -481.82%-168M |
| Noncontrolling interests | 428M | 352M | 10,525.00%417M | 3,100.00%32M | 0 | 50.00%-4M | 20.00%-4M | 0 | 1M | -133.33%-1M |
| Net income attributable to the company | 179M | -365.45%-507M | 75.49%-650M | 30.79%-517M | 214.37%191M | 0.75%-2.65B | 22.79%-1.39B | 14.46%-349M | -47.92%-747M | -517.50%-167M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 179M | -365.45%-507M | 75.49%-650M | 30.79%-517M | 214.37%191M | 0.75%-2.65B | 22.79%-1.39B | 14.46%-349M | -47.92%-747M | -517.50%-167M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 1.31 | -349.66%-3.72 | 78.69%-4.85 | 38.32%-3.96 | 202.05%1.49 | 4.49%-22.76 | 25.72%-11.9 | 17.91%-2.98 | -41.41%-6.42 | -505.56%-1.46 |
| Diluted earnings per share | 1.31 | -349.66%-3.72 | 78.69%-4.85 | 38.32%-3.96 | 202.05%1.49 | 4.49%-22.76 | 25.72%-11.9 | 17.91%-2.98 | -41.41%-6.42 | -505.56%-1.46 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |